Cargando…
TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
BACKGROUND: Inclusions of TAR DNA-binding protein 43 kDa (TDP-43) has been designated limbic-predominant, age-related TDP-43 encephalopathy (LATE), with or without co-occurrence of Alzheimer’s disease (AD). Approximately, 30–70% AD cases present TDP-43 proteinopathy (AD-TDP), and a greater disease s...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441763/ https://www.ncbi.nlm.nih.gov/pubmed/37605276 http://dx.doi.org/10.1186/s13024-023-00646-z |
_version_ | 1785093444166746112 |
---|---|
author | Estades Ayuso, Virginia Pickles, Sarah Todd, Tiffany Yue, Mei Jansen-West, Karen Song, Yuping González Bejarano, Jesús Rawlinson, Bailey DeTure, Michael Graff-Radford, Neill R. Boeve, Bradley F. Knopman, David S. Petersen, Ronald C. Dickson, Dennis W. Josephs, Keith A. Petrucelli, Leonard Prudencio, Mercedes |
author_facet | Estades Ayuso, Virginia Pickles, Sarah Todd, Tiffany Yue, Mei Jansen-West, Karen Song, Yuping González Bejarano, Jesús Rawlinson, Bailey DeTure, Michael Graff-Radford, Neill R. Boeve, Bradley F. Knopman, David S. Petersen, Ronald C. Dickson, Dennis W. Josephs, Keith A. Petrucelli, Leonard Prudencio, Mercedes |
author_sort | Estades Ayuso, Virginia |
collection | PubMed |
description | BACKGROUND: Inclusions of TAR DNA-binding protein 43 kDa (TDP-43) has been designated limbic-predominant, age-related TDP-43 encephalopathy (LATE), with or without co-occurrence of Alzheimer’s disease (AD). Approximately, 30–70% AD cases present TDP-43 proteinopathy (AD-TDP), and a greater disease severity compared to AD patients without TDP-43 pathology. However, it remains unclear to what extent TDP-43 dysfunction is involved in AD pathogenesis. METHODS: To investigate whether TDP-43 dysfunction is a prominent feature in AD-TDP cases, we evaluated whether non-conserved cryptic exons, which serve as a marker of TDP-43 dysfunction in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), accumulate in AD-TDP brains. We assessed a cohort of 192 post-mortem brains from three different brain regions: amygdala, hippocampus, and frontal cortex. Following RNA and protein extraction, qRT-PCR and immunoassays were performed to quantify the accumulation of cryptic RNA targets and phosphorylated TDP-43 pathology, respectively. RESULTS: We detected the accumulation of misspliced cryptic or skiptic RNAs of STMN2, KCNQ2, UNC13A, CAMK2B, and SYT7 in the amygdala and hippocampus of AD-TDP cases. The topographic distribution of cryptic RNA accumulation mimicked that of phosphorylated TDP-43, regardless of TDP-43 subtype classification. Further, cryptic RNAs efficiently discriminated AD-TDP cases from controls. CONCLUSIONS: Overall, our results indicate that cryptic RNAs may represent an intriguing new therapeutic and diagnostic target in AD, and that methods aimed at detecting and measuring these species in patient biofluids could be used as a reliable tool to assess TDP-43 pathology in AD. Our work also raises the possibility that TDP-43 dysfunction and related changes in cryptic splicing could represent a common molecular mechanism shared between AD-TDP and FTLD-TDP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13024-023-00646-z. |
format | Online Article Text |
id | pubmed-10441763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104417632023-08-22 TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains Estades Ayuso, Virginia Pickles, Sarah Todd, Tiffany Yue, Mei Jansen-West, Karen Song, Yuping González Bejarano, Jesús Rawlinson, Bailey DeTure, Michael Graff-Radford, Neill R. Boeve, Bradley F. Knopman, David S. Petersen, Ronald C. Dickson, Dennis W. Josephs, Keith A. Petrucelli, Leonard Prudencio, Mercedes Mol Neurodegener Research Article BACKGROUND: Inclusions of TAR DNA-binding protein 43 kDa (TDP-43) has been designated limbic-predominant, age-related TDP-43 encephalopathy (LATE), with or without co-occurrence of Alzheimer’s disease (AD). Approximately, 30–70% AD cases present TDP-43 proteinopathy (AD-TDP), and a greater disease severity compared to AD patients without TDP-43 pathology. However, it remains unclear to what extent TDP-43 dysfunction is involved in AD pathogenesis. METHODS: To investigate whether TDP-43 dysfunction is a prominent feature in AD-TDP cases, we evaluated whether non-conserved cryptic exons, which serve as a marker of TDP-43 dysfunction in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), accumulate in AD-TDP brains. We assessed a cohort of 192 post-mortem brains from three different brain regions: amygdala, hippocampus, and frontal cortex. Following RNA and protein extraction, qRT-PCR and immunoassays were performed to quantify the accumulation of cryptic RNA targets and phosphorylated TDP-43 pathology, respectively. RESULTS: We detected the accumulation of misspliced cryptic or skiptic RNAs of STMN2, KCNQ2, UNC13A, CAMK2B, and SYT7 in the amygdala and hippocampus of AD-TDP cases. The topographic distribution of cryptic RNA accumulation mimicked that of phosphorylated TDP-43, regardless of TDP-43 subtype classification. Further, cryptic RNAs efficiently discriminated AD-TDP cases from controls. CONCLUSIONS: Overall, our results indicate that cryptic RNAs may represent an intriguing new therapeutic and diagnostic target in AD, and that methods aimed at detecting and measuring these species in patient biofluids could be used as a reliable tool to assess TDP-43 pathology in AD. Our work also raises the possibility that TDP-43 dysfunction and related changes in cryptic splicing could represent a common molecular mechanism shared between AD-TDP and FTLD-TDP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13024-023-00646-z. BioMed Central 2023-08-21 /pmc/articles/PMC10441763/ /pubmed/37605276 http://dx.doi.org/10.1186/s13024-023-00646-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Estades Ayuso, Virginia Pickles, Sarah Todd, Tiffany Yue, Mei Jansen-West, Karen Song, Yuping González Bejarano, Jesús Rawlinson, Bailey DeTure, Michael Graff-Radford, Neill R. Boeve, Bradley F. Knopman, David S. Petersen, Ronald C. Dickson, Dennis W. Josephs, Keith A. Petrucelli, Leonard Prudencio, Mercedes TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains |
title | TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains |
title_full | TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains |
title_fullStr | TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains |
title_full_unstemmed | TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains |
title_short | TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains |
title_sort | tdp-43-regulated cryptic rnas accumulate in alzheimer’s disease brains |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441763/ https://www.ncbi.nlm.nih.gov/pubmed/37605276 http://dx.doi.org/10.1186/s13024-023-00646-z |
work_keys_str_mv | AT estadesayusovirginia tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT picklessarah tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT toddtiffany tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT yuemei tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT jansenwestkaren tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT songyuping tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT gonzalezbejaranojesus tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT rawlinsonbailey tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT deturemichael tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT graffradfordneillr tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT boevebradleyf tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT knopmandavids tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT petersenronaldc tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT dicksondennisw tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT josephskeitha tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT petrucellileonard tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains AT prudenciomercedes tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains |